Great post.
The poster you responding to is clearly a downramper.
Its not that we don't value other side of the coin, but comments like this "I'm aware of for this asset is their diabetes kidney disease study, but I read that flopped" clearly shows misrepresentation of facts.
On the basis of the "Flopped" DKD trial, Dimerix announced that it has entered into an agreement with the Australian Centre for Accelerating Diabetes Innovation (ACADI) to commence a clinical trial on diabetic kidney disease (expected to commence Q4 this year).
The reason it hasn't progressed coz Dimerix is fully focused on FSGS...I am sure we will hear about DKD and COPD in due course...
- Forums
- ASX - By Stock
- DXB
- Ann: AGM Presentation
Ann: AGM Presentation, page-62
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $214.4M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 37.0¢ | $503.5K | 1.322M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 26318 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 170072 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1318 | 0.380 |
3 | 72579 | 0.375 |
4 | 134161 | 0.370 |
1 | 30000 | 0.365 |
4 | 27499 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 140963 | 5 |
0.395 | 61740 | 2 |
0.400 | 115000 | 2 |
0.405 | 86528 | 4 |
0.410 | 56400 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |